Benzinga | Aug 17, 2021 03:37PM EDT

Ovid Therapeutics Granted Patent 'Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering'

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6670&f=G&l=50&d=PTXT&p=134&S1=20210817&OS=20210817&RS=20210817